Clinical Trials Browser

Phase 2 × Hemangioma, Cavernous, Central Nervous System × Clear all

NCT05085561 2025-08-06

SYCAMORE

Phase 2 Completed

Hemangioma, Cavernous, Central Nervous System

NCT03474614 2024-04-19

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Phase 2 Terminated

Hemangioma, Cavernous, Central Nervous System

NCT03589014 2022-02-25

Treat_CCM

Phase 2 Completed

Hemangioma, Cavernous, Central Nervous System